Why Did Cathie Wood Buy AMD?
Noted tech investor Cathie Wood has used the recent stock…
Buy
70
CAH Quote, Financials, Valuation and Earnings
Last price:
$149.58
Seasonality move
:
4.77%
Day range:
$146.35 - $150.12
52-week range:
$93.17 - $150.12
Dividend yield:
1.35%
P/E ratio:
23.33x
P/S ratio:
0.16x
P/B ratio:
--
Volume:
3.3M
Avg. volume:
2.8M
1-year change:
45.2%
Market cap:
$36.1B
Revenue:
$226.8B
EPS (TTM):
$6.41
Analysts' Opinion
-
Consensus RatingCardinal Health has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $153.14, Cardinal Health has an estimated upside of 2.42% from its current price of $149.53.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $119.12 representing 20.34% downside risk from its current price of $149.53.
Fair Value
-
According to the consensus of 14 analysts, Cardinal Health has 2.42% upside to fair value with a price target of $153.14 per share.
CAH vs. S&P 500
-
Over the past 5 trading days, Cardinal Health has overperformed the S&P 500 by 5.62% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cardinal Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cardinal Health has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Cardinal Health reported revenues of $54.9B.
Earnings Growth
-
Cardinal Health has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Cardinal Health reported earnings per share of $2.10.
Enterprise value:
41.5B
EV / Invested capital:
--
Price / LTM sales:
0.16x
EV / EBIT:
18.39x
EV / Revenue:
0.19x
PEG ratio (5yr expected):
0.13x
EV / Free cash flow:
16.99x
Price / Operating cash flow:
14.93x
Enterprise value / EBITDA:
13.73x
Gross Profit (TTM):
$7.8B
Return On Assets:
3.37%
Net Income Margin (TTM):
0.7%
Return On Equity:
--
Return On Invested Capital:
46.27%
Operating Margin:
1.2%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $198.6B | $220.4B | $222.3B | $54.9B | $54.9B | |
| Gross Profit | $6.6B | $7.3B | $7.8B | $1.9B | $2.1B | |
| Operating Income | $1.6B | $2.1B | $2.3B | $586M | $656M | |
| EBITDA | $1.3B | $1.7B | $3B | $547M | $946M | |
| Diluted EPS | $1.74 | $2.27 | $6.41 | $1.07 | $2.10 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $30.4B | $30.9B | $33.5B | $35.7B | $34.6B | |
| Total Assets | $43.9B | $42.1B | $43.4B | $45.9B | $49.9B | |
| Current Liabilities | $25.3B | $28.7B | $32.5B | $36.3B | $36.7B | |
| Total Liabilities | $42.1B | $42.8B | $45.6B | $49.1B | $51.8B | |
| Total Equity | $1.8B | -$693M | -$2.2B | -$3.3B | -$1.9B | |
| Total Debt | $6.7B | $5.6B | $4.7B | $5.9B | $7.7B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $5B | $2.5B | $3B | -$27M | $2.9B | |
| Cash From Investing | -$452M | -$2.2B | -$3.8B | -$1.8B | -$2.9B | |
| Cash From Financing | -$2.9B | -$580M | $425M | $1B | -$507M | |
| Free Cash Flow | $4.6B | $2B | $2.4B | -$139M | $2.8B | |
CAH
Sector
Market Cap
$36.1B
$35.8M
Price % of 52-Week High
99.61%
45.38%
Dividend Yield
1.35%
0%
Shareholder Yield
1.99%
-0.81%
1-Year Price Total Return
45.2%
-38.89%
Beta (5-Year)
0.662
0.662
Dividend yield:
1.35%
Annualized payout:
$1.50
Payout ratio:
31.86%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$140.28
200-day SMA
Buy
Level
$118.94
Bollinger Bands (100)
Buy
Level
120.97 - 134.37
Chaikin Money Flow
Buy
Level
552.4M
20-day SMA
Buy
Level
$134.83
Relative Strength Index (RSI14)
Buy
Level
75.69
ADX Line
Buy
Level
20.13
Williams %R
Sell
Level
-2.8641
50-day SMA
Buy
Level
$132.27
MACD (12, 26)
Buy
Level
3.42
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
254.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.3875)
Sell
CA Score
(Annual)
Level (-0.936)
Buy
Beneish M-Score
(Annual)
Level (-2.6731)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (2.2255)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Stock Forecast FAQ
In the current month, CAH has received 9 Buy ratings 5 Hold ratings, and 0 Sell ratings. The CAH average analyst price target in the past 3 months is $153.14.
-
Where Will Cardinal Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cardinal Health share price will rise to $153.14 per share over the next 12 months.
-
What Do Analysts Say About Cardinal Health?
Analysts are divided on their view about Cardinal Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cardinal Health is a Sell and believe this share price will drop from its current level to $119.12.
-
What Is Cardinal Health's Price Target?
The price target for Cardinal Health over the next 1-year time period is forecast to be $153.14 according to 14 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is CAH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cardinal Health is a Buy. 9 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CAH?
You can purchase shares of Cardinal Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cardinal Health shares.
-
What Is The Cardinal Health Share Price Today?
Cardinal Health was last trading at $149.58 per share. This represents the most recent stock quote for Cardinal Health. Yesterday, Cardinal Health closed at $149.53 per share.
-
How To Buy Cardinal Health Stock Online?
In order to purchase Cardinal Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Salesforce Stock Drop After a Strong Quarter?
Popular customer relationship management platform provider Salesforce (NYSE:CRM) has been…
Is Adobe Stock a Bargain With AI Tools Driving Growth?
The share price of American computer software company Adobe (NASDAQ:ADBE)…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Sell
4
CABO alert for May 3
Cable One [CABO] is down 41.98% over the past day.
Buy
55
PDEX alert for May 3
Pro-Dex [PDEX] is down 32.02% over the past day.
Buy
91
TRUP alert for May 3
Trupanion [TRUP] is up 23.52% over the past day.
